Nitazoxanide : Nitazoxanide and COVID-19: A review
Adavosertib : Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trial
AUZ454 : CDK 4/6 inhibitor successful rechallenge after limiting hepatic toxicity
CTx-648 : HDAC inhibition prevents hypobaric hypoxia-induced spatial memory impairment through PΙ3K/GSK3β/CREB pathway
Bortezomib: MULTIPLE MYELOMA WITH ADVANCED BONE DISEASE AND LOW TUMOR BURDEN– DIFFERENT CLINICAL PRESENTATION BUT SIMILAR OUTCOME AFTER BORTEZOMIB-BASED THERAPY AND RADIOTHERAPY